Gland Pharma extends losses for second straight session, corrects over 10%

Gland Pharma share price NSE, Gland Pharma stock price target: Gland Pharma shares extended losses for the second straight session on Monday. The trend follows after the Hyderabad-based generic injectable manufacturer reported a 52 per cent fall in operating profit to Rs 168 crore for the quarter that ended March 2023. The mid-cap pharma company shares on Monday opened at Rs 950 apiece on NSE. At, 10:49 AM, the stock quoted Rs 957.5, down by 10.14 per cent or 108.1 points. The stock on Friday had locked in the 20 per cent lower circuit at Rs 1,065.6 levels .

Gland Pharma Q4 results

Gland Pharma reported a 29 per cent fall in revenue to Rs 785 crore. The company's margin contracted to 21.5 per cent from 31.6 per cent a year ago.

Gland Pharma share price target: Should you buy, sell or hold?

Post the drug maker's earnings announcement, brokerages have mixed views on the counter.

• Goldman Sachs maintained a 'buy' on Gland Pharma but reduced its target price to Rs 1,475 from Rs 1,700.  
• Citi continued with a 'sell' call and reduced its target price to Rs 925 from Rs 1,200.
• Jefferies retained an 'underperform' rating with a target price of Rs 1,065.  
• Gland Pharma shares: Past performance

On a year-to-date basis (as of May 22), Gland Pharma shares have lost nearly 69 per cent of their value in the past year, a period in which the Nifty headline index has fallen 13 per cent.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com